Organon
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
3- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 81.1%
- Company has been maintaining a healthy dividend payout of 238%
Weaknesses
3- The company has delivered a poor sales growth of -9.70% over past five years.
- Earnings include an other income of Rs.11.4 Cr.
- Working capital days have increased from 138 days to 254 days
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Profit & Loss
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 15m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 175 | 171 | 151 | 159 | 168 | 186 | 216 | 283 | 223 | 227 | 183 | 129 |
| Expenses | 149 | 148 | 133 | 128 | 138 | 156 | 184 | 224 | 198 | 186 | 156 | 121 |
| Operating Profit | 25 | 22 | 18 | 32 | 29 | 30 | 32 | 59 | 25 | 41 | 27 | 9 |
| OPM % | 14% | 13% | 12% | 20% | 17% | 16% | 15% | 21% | 11% | 18% | 15% | 7% |
| Other Income | 5 | 8 | 9 | 10 | 6 | 0 | 0 | 0 | 19 | 108 | 388 | 11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| PBT | 29 | 30 | 25 | 40 | 35 | 30 | 32 | 59 | 44 | 148 | 414 | 19 |
| Tax % | 37% | 39% | 41% | 35% | 32% | 34% | 33% | 35% | 33% | 28% | 24% | 36% |
| Net Profit | 18 | 18 | 15 | 26 | 23 | 19 | 21 | 38 | 29 | 107 | 313 | 12 |
| Div. Payout % | 17% | 17% | 217% | 5% | 12% | 0% | 0% | 74% | 0% | 155% | 72% | 487% |
Balance Sheet
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 119 | 133 | 112 | 136 | 157 | 183 | 204 | 209 | 239 | 146 | 187 | 127 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 24 | 27 | 38 | 31 | 33 | 34 | 48 | 66 | 48 | 151 | 55 | 55 |
| Total Liabilities | 150 | 166 | 156 | 174 | 196 | 223 | 259 | 281 | 292 | 303 | 247 | 189 |
| Fixed Assets | 7 | 10 | 9 | 8 | 10 | 11 | 9 | 8 | 7 | 7 | 7 | 7 |
| CWIP | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 136 | 152 | 144 | 166 | 186 | 212 | 249 | 273 | 285 | 295 | 240 | 181 |
| Total Assets | 150 | 166 | 156 | 174 | 196 | 223 | 259 | 281 | 292 | 303 | 247 | 189 |
Cash Flow
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 8 | 24 | 21 | 13 | -1 | 24 | 25 | 11 | 1 | 120 | 307 | -28 |
| Investing | -27 | 17 | -8 | 6 | 8 | 7 | -72 | -20 | 75 | 18 | 18 | 11 |
| Financing | -4 | -4 | -37 | -4 | -1 | 0 | -1 | 0 | -33 | -100 | -372 | -52 |
| Net Cash Flow | -23 | 37 | -25 | 15 | 6 | 30 | -48 | -9 | 43 | 38 | -47 | -69 |
| Free Cash Flow | 7 | 23 | 21 | 13 | -3 | 22 | 24 | 11 | 1 | 120 | 306 | -28 |
| CFO/OP | 68 | 170 | 194 | 75 | 42 | 120 | 125 | 52 | 74 | 390 | 1,527 | -211 |
Ratios
| Particulars | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50 | 33 | 35 | 29 | 35 | 27 | 7 | 4 | 6 | 6 | 5 | 4 |
| Inventory Days | 144 | 130 | 119 | 165 | 256 | — | — | — | 131 | 118 | 87 | 122 |
| Days Payable | 105 | 112 | 143 | 129 | 117 | — | — | — | 111 | 107 | 121 | 238 |
| Cash Conversion Cycle | 89 | 52 | 11 | 65 | 174 | 27 | 7 | 4 | 26 | 17 | -29 | -112 |
| Working Capital Days | 141 | 85 | 121 | 144 | 159 | 102 | 202 | 176 | 161 | -10 | 170 | 254 |
| ROCE % | — | 22% | 19% | 31% | 23% | — | 16% | 28% | 19% | 75% | 241% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Organon insights
28 extracted metrics + investor summaries across FY05–FY18.
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INFARINDIA.md for Organon (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.